234 related articles for article (PubMed ID: 28471848)
21. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
[TBL] [Abstract][Full Text] [Related]
22. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
23. Pep-1&borneol-Bifunctionalized Carmustine-Loaded Micelles Enhance Anti-Glioma Efficacy Through Tumor-Targeting and BBB-Penetrating.
Guo X; Wu G; Wang H; Chen L
J Pharm Sci; 2019 May; 108(5):1726-1735. PubMed ID: 30537472
[TBL] [Abstract][Full Text] [Related]
24. Research progress on the regulation and mechanism of borneol on the blood-brain barrier in pathological states: a narrative review focused on ischemic stroke and cerebral glioma.
Tan X; Zhang K; Shi W; Tang Z
Transl Cancer Res; 2023 Nov; 12(11):3198-3209. PubMed ID: 38130309
[TBL] [Abstract][Full Text] [Related]
25. Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment.
Liu HL; Huang CY; Chen JY; Wang HY; Chen PY; Wei KC
PLoS One; 2014; 9(12):e114311. PubMed ID: 25490097
[TBL] [Abstract][Full Text] [Related]
26. Focused Ultrasound Enhances Central Nervous System Delivery of Bevacizumab for Malignant Glioma Treatment.
Liu HL; Hsu PH; Lin CY; Huang CW; Chai WY; Chu PC; Huang CY; Chen PY; Yang LY; Kuo JS; Wei KC
Radiology; 2016 Oct; 281(1):99-108. PubMed ID: 27192459
[TBL] [Abstract][Full Text] [Related]
27. Borneol and Α-asarone as adjuvant agents for improving blood-brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors.
Wu JY; Li YJ; Yang L; Hu YY; Hu XB; Tang TT; Wang JM; Liu XY; Xiang DX
Drug Deliv; 2018 Nov; 25(1):1858-1864. PubMed ID: 30338713
[TBL] [Abstract][Full Text] [Related]
28. Inducing a Transient Increase in Blood-Brain Barrier Permeability for Improved Liposomal Drug Therapy of Glioblastoma Multiforme.
Lundy DJ; Lee KJ; Peng IC; Hsu CH; Lin JH; Chen KH; Tien YW; Hsieh PCH
ACS Nano; 2019 Jan; 13(1):97-113. PubMed ID: 30532951
[TBL] [Abstract][Full Text] [Related]
29. Borneol Depresses P-Glycoprotein Function by a NF-κB Signaling Mediated Mechanism in a Blood Brain Barrier in Vitro Model.
Fan X; Chai L; Zhang H; Wang Y; Zhang B; Gao X
Int J Mol Sci; 2015 Nov; 16(11):27576-88. PubMed ID: 26593909
[TBL] [Abstract][Full Text] [Related]
30. [Borneol promotes oral absorption and penetration into brain of puerarin and catalpol].
Tang DD; Zhang J; Wang JR; Zhang JF; Xu XY
Zhongguo Zhong Yao Za Zhi; 2016 Jul; 41(14):2720-2726. PubMed ID: 28905612
[TBL] [Abstract][Full Text] [Related]
31. Pulsed high-intensity focused ultrasound enhances the relative permeability of the blood-tumor barrier in a glioma-bearing rat model.
Yang FY; Lin GL; Horng SC; Chang TK; Wu SY; Wong TT; Wang HE
IEEE Trans Ultrason Ferroelectr Freq Control; 2011 May; 58(5):964-70. PubMed ID: 21622052
[TBL] [Abstract][Full Text] [Related]
32. Corticotropin-releasing factor decreases vasogenic brain edema.
Tjuvajev J; Uehara H; Desai R; Beattie B; Matei C; Zhou Y; Kreek MJ; Koutcher J; Blasberg R
Cancer Res; 1996 Mar; 56(6):1352-60. PubMed ID: 8640825
[TBL] [Abstract][Full Text] [Related]
33. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma.
Neuwelt EA; Howieson J; Frenkel EP; Specht HD; Weigel R; Buchan CG; Hill SA
Neurosurgery; 1986 Oct; 19(4):573-82. PubMed ID: 3097567
[TBL] [Abstract][Full Text] [Related]
35. Capillary permeability in experimental rat glioma and effects of intracarotid CDDP administration on tumor drug delivery.
Ichimura K; Ohno K; Aoyagi M; Tamaki M; Suzuki R; Hirakawa K
J Neurooncol; 1993 Jun; 16(3):211-5. PubMed ID: 8301345
[TBL] [Abstract][Full Text] [Related]
36. Optimization of the Preparation Conditions of Borneol-Modified Ginkgolide Liposomes by Response Surface Methodology and Study of Their Blood Brain Barrier Permeability.
Lv Z; Yang Y; Wang J; Chen J; Li J; Di L
Molecules; 2018 Jan; 23(2):. PubMed ID: 29385087
[TBL] [Abstract][Full Text] [Related]
37. Penetration of blood-brain barrier and antitumor activity and nerve repair in glioma by doxorubicin-loaded monosialoganglioside micelles system.
Zou D; Wang W; Lei D; Yin Y; Ren P; Chen J; Yin T; Wang B; Wang G; Wang Y
Int J Nanomedicine; 2017; 12():4879-4889. PubMed ID: 28744122
[TBL] [Abstract][Full Text] [Related]
38. Peripheral ammonia and blood brain barrier structure and function after methamphetamine.
Northrop NA; Halpin LE; Yamamoto BK
Neuropharmacology; 2016 Aug; 107():18-26. PubMed ID: 26972828
[TBL] [Abstract][Full Text] [Related]
39. Improved blood-brain barrier distribution: effect of borneol on the brain pharmacokinetics of kaempferol in rats by in vivo microdialysis sampling.
Zhang Q; Wu D; Wu J; Ou Y; Mu C; Han B; Zhang Q
J Ethnopharmacol; 2015 Mar; 162():270-7. PubMed ID: 25582491
[TBL] [Abstract][Full Text] [Related]
40. Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.
Liu HL; Yang HW; Hua MY; Wei KC
Neurosurg Focus; 2012 Jan; 32(1):E4. PubMed ID: 22208897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
